Drugs / Norovirus Bivalent VLP Vaccine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02142504 | May 2014 → Jan 2016 | — | Takeda | Completed | No outcome recorded |
| Phase 2 | NCT02038907 | Mar 2014 → Jun 2015 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norovirus Bivalent VLP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02038907 ↗ |
| Modality | Vaccine | “norovirus vaccine” NCT02038907 ↗ |
| Route | Intramuscular | “Norovirus GI.1/GII.4 bivalent VLP vaccine IM injection” NCT02038907 ↗ |